Abstract
A new series of 1'-(4-chlorophenyl)-5-(substituted aryl)-3'-(substituted aryl)-3,4-dihydro-2H, 1'H-[3,4']bipyrazolyl derivatives (6a-e, 8a-e, 10a-e) have been synthesized, characterized and screened for antimicrobial and antitubercular activity. Among the synthesized compounds, the minimum inhibition concentration of 10e was found to be as low as 1.56 mu g ml(-1) and that of 10c was 6.25 mu g ml(-1) as compared to the standard anti-tb drugs pyrazinamide and streptomycin.